hypocrisy, page-2

here we are, waiting to get back to where we were a year out from approval.

On the plus side since then, we have approval and we're past the initial sales start up period. On the downside, we're getting 50% instead of 60%. And we've had 40% dilution from the capital raising.

Taking both of those into account, effectively we are up about 20% from the pre-approval share price. Doesn't seem completely unreasonable - my prediction for the post-approval share price was $1, which would be about 60c adjusted.